Description
RESFLU S 500 is a combination inhalation therapy designed to provide effective management of asthma and chronic obstructive pulmonary disease (COPD). It combines Salmeterol, a long-acting beta-2 agonist (LABA), with Fluticasone Propionate, a corticosteroid. Together, they work to provide long-term bronchodilation and anti-inflammatory action, ensuring easier breathing and better control of chronic respiratory conditions.
Benefits of RESFLU S 500
Dual-action formula for both bronchodilation and inflammation control
Provides long-lasting relief from asthma and COPD symptoms
Reduces wheezing, breathlessness, and nighttime coughing
Lowers the risk of asthma attacks and COPD exacerbations
Improves lung function and quality of life
